The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist.
about
Inflammation and prolonged QT time: results from the Cardiovascular Disease, Living and Ageing in Halle (CARLA) studyInflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal DialysisSmoking and atherosclerotic cardiovascular disease: part II: role of cigarette smoking in cardiovascular disease development.Anti-inflammatory effect of cardiac resynchronization therapy.
P2860
The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The enhanced plasma levels of ...... beta-adrenoceptor antagonist.
@ast
The enhanced plasma levels of ...... beta-adrenoceptor antagonist.
@en
type
label
The enhanced plasma levels of ...... beta-adrenoceptor antagonist.
@ast
The enhanced plasma levels of ...... beta-adrenoceptor antagonist.
@en
prefLabel
The enhanced plasma levels of ...... beta-adrenoceptor antagonist.
@ast
The enhanced plasma levels of ...... beta-adrenoceptor antagonist.
@en
P2860
P1476
The enhanced plasma levels of ...... beta-adrenoceptor antagonist.
@en
P2093
Claudia Werner
Harald Loppnow
P2860
P356
10.1046/J.1474-8673.2002.00245.X
P50
P577
2002-04-01T00:00:00Z